Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:25
CBS 58’s Hometown Athlete: Messmer’s Vito Velazquez looks...
-
1:57
Kenosha school board passes policy allowing metal detecting wands...
-
2:22
City of Milwaukee sues leading fire truck manufacturers, alleging...
-
0:40
Travelers land in Milwaukee after violent weekend in Puerto Vallerta
-
2:31
’I will miss her so much’: Family identifies 84-year-old...
-
1:53
10 Wisconsin-based businesses sue federal government, seek to...
-
2:56
Packers GM says Green Bay is a draft and development team
-
2:35
Proposal aims to raise minimum wage in Wisconsin
-
2:48
School districts, teachers, parents suing Legislature over state...
-
1:07
Milwaukee’s sprinkler system ordinance approved, reducing financial...
-
2:14
WisDOT joins CBS 58 to discuss area construction projects
-
2:07
The INN in Hartland mixes global cuisine with local history
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.